| New use of BCG for recombinant vaccines CK Stover, VF De La Cruz, TR Fuerst, JE Burlein, LA Benson, LT Bennett, ... Nature 351 (6326), 456-460, 1991 | 1801 | 1991 |
| Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus S Johnson, C Oliver, GA Prince, VG Hemming, DS Pfarr, SC Wang, ... Journal of Infectious Diseases 176 (5), 1215-1224, 1997 | 748 | 1997 |
| Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. CK Stover, GP Bansal, MS Hanson, JE Burlein, SR Palaszynski, JF Young, ... The Journal of experimental medicine 178 (1), 197-209, 1993 | 352 | 1993 |
| Candidate recombinant vaccine for human B19 parvovirus GP Bansal, JA Hatfield, FE Dunn, AA Kramer, F Brady, CH Riggin, ... Journal of Infectious Diseases 167 (5), 1034-1044, 1993 | 161 | 1993 |
| Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. SJ Rosenfeld, K Yoshimoto, S Kajigaya, S Anderson, NS Young, A Field, ... The Journal of clinical investigation 89 (6), 2023-2029, 1992 | 147 | 1992 |
| Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta. SM Wahl, DA Hunt, G Bansal, N McCartney-Francis, L Ellingsworth, ... The Journal of experimental medicine 168 (4), 1403-1417, 1988 | 112 | 1988 |
| Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles R Kumar, PC Ray, D Datta, GP Bansal, E Angov, N Kumar Vaccine 33 (39), 5064-5071, 2015 | 110 | 2015 |
| MRI texture analysis predicts p53 status in head and neck squamous cell carcinoma M Dang, JT Lysack, T Wu, TW Matthews, SP Chandarana, NT Brockton, ... American Journal of Neuroradiology 36 (1), 166-170, 2015 | 98 | 2015 |
| Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a … R Edelman, K Palmer, KG Russ, HP Secrest, JAL Becker, SA Bodison, ... Vaccine 17 (7-8), 904-914, 1999 | 89 | 1999 |
| Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates M Robert-Guroff, K Aldrich, R Muldoon, TL Stern, GP Bansal, TJ Matthews, ... Journal of virology 66 (6), 3602-3608, 1992 | 81 | 1992 |
| Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis T Kamradt, B Lengl-Janssen, AF Strauss, G Bansal, AC Steere Infection and immunity 64 (4), 1284-1289, 1996 | 60 | 1996 |
| Effect of anti‐V3 antibodies on cell‐free and cell‐to‐cell human immunodeficiency virus transmission G Pantaleo, JF Demarest, M Vaccarezza, C Graziosi, GP Bansal, ... European journal of immunology 25 (1), 226-231, 1995 | 53 | 1995 |
| Use of recombinant BCG as a vaccine delivery vehicle CK Stover, VF De la Cruz, GP Bansal, MS Hanson, TR Fuerst, WR Jacobs, ... Advances in Experimental Medicine and Biology, 175-182, 1992 | 51 | 1992 |
| HIV-related stigma research as a priority at the National Institutes of Health GL Greenwood, A Wilson, GP Bansal, C Barnhart, E Barr, R Berzon, ... AIDS and Behavior 26 (Suppl 1), 5-26, 2022 | 44 | 2022 |
| Future paths for HIV vaccine research: Exploiting results from recent clinical trials and current scientific advances. GP Bansal, A Malaspina, J Flores Current Opinion in Molecular Therapeutics 12 (1), 39-46, 2010 | 36 | 2010 |
| Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross–Boosting of Immune … Y Cao, GP Bansal, K Merino, N Kumar PloS one 11 (7), e0158212, 2016 | 33 | 2016 |
| A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 … GP Bansal Biologicals 35 (4), 367-371, 2007 | 32 | 2007 |
| Protective immunity elicited by rBCG vaccines. CK Stover, GP Bansal, S Langerman, MS Hanson Developments in biological standardization 82, 163-170, 1994 | 26 | 1994 |
| Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric … R Kumar, G Ledet, R Graves, D Datta, S Robinson, GP Bansal, T Mandal, ... Pharmaceutical research 32, 3827-3836, 2015 | 24 | 2015 |
| Efficacy and safety of live recombinant BCG vaccines. MS Hanson, GP Bansal, S Langermann, CK Stover, I Orme Developments in biological standardization 84, 229-236, 1995 | 23 | 1995 |
